The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Reder, Anthony T.
Item TypeName
Concept Immunosuppressive Agents
Academic Article Fingolimod for the treatment of relapsing multiple sclerosis.
Academic Article Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon beta-1b.
Academic Article Cystoid macular edema associated with fingolimod use for multiple sclerosis.
Academic Article Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis.
Academic Article Varicella-zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for management.
Academic Article Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial.
Academic Article First-dose effects of fingolimod: Pooled safety data from three phase 3 studies.
Academic Article The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple Sclerosis.
Academic Article Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: A case report and review of literature.
Academic Article Dimethyl fumarate-induced changes in the MS lymphocyte repertoire: No need for subset monitoring.
Academic Article Disability improvement as a clinically relevant outcome in clinical trials of relapsing forms of multiple sclerosis.
Academic Article COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies.
Academic Article Medications for Multiple Sclerosis and Risk of Malignancy: What Next?
Academic Article Increased Percentage of CD8+CD28- Regulatory T Cells With Fingolimod Therapy in Multiple Sclerosis.
Academic Article Effectiveness of rituximab versus oral immunosuppressive therapies in neuromyelitis optica spectrum disorder in a racially diverse cohort of subjects: A single-center retrospective study.
Search Criteria
  • Immunosuppressive Agents